Fundamental analysis PEVE.JK (PT. Penta Valent Tbk)

Updated on 09/07/2026

Method and analysis by Lubin Danilo, founder of Lubin Investment. Score computed automatically, with no human opinion.

We analyzed PT. Penta Valent Tbk stock against the 10 quality criteria of Lubin Investment. The company gets a quality score of 5/10, meaning medium quality.

Sector: Pharmaceutical Retailers. Listing: JK. Current price: 322.00 IDR.

Lubin scoring methodology

PT. Penta Valent Tbk (PEVE.JK)'s score is calculated automatically from 10 objective financial criteria, with no human intervention or opinion. Each criterion is validated (YES / PARTIAL / NO) based on thresholds drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran). The final score is the sum of validations.

The thresholds come from the financial literature, not from our preferences: see the valuation work of Aswath Damodaran (NYU Stern) and the SEC investor education resources (investor.gov).

The 10 quantitative criteria analyzed

1. Profitable: net margin > 5%
2. Growing revenue: revenue growing > 10%/year over 5 years
3. Growing earnings per share: FCF per share adjusted for stock-based compensation, > 10%/year over 5 years
4. Share count under control: stable or declining (net buybacks = value creation for shareholders)
5. Growing revenue per employee: revenue and revenue per employee both grow ≥ 10%/year over 5 years; partial when only one growth driver reaches its tier (fallback: free cash flow margin > 10% when employee history is unavailable)
6. Expanding margins: operating margin widens over 5 years (operating leverage)
7. Return on invested capital: Cash ROCE > 15% per year
8. Debt under control: net debt repayable in less than 3 years of free cash flow
9. Earnings converted to cash: free cash flow exceeds accounting net income
10. Net collection period: short or negative cash conversion cycle

Frequently asked questions

Is PT. Penta Valent Tbk a quality stock?

PT. Penta Valent Tbk gets a quality score of 5/10 (medium quality), calculated over the 10 Lubin Investment criteria: profitability, revenue and free cash flow growth, share buybacks, margins, debt and return on capital.

How is PT. Penta Valent Tbk's score calculated?

The score is the total of validated criteria (YES / PARTIAL / NO) using thresholds drawn from the financial literature (Warren Buffett, Mauboussin, Aswath Damodaran), automatically and with no human opinion.

Where to see PT. Penta Valent Tbk's full analysis?

The full interactive analysis (10-criteria detail, history, P/FCF valuation, sector comparisons) is available at https://lubin-investment.com/analyse/PEVE.JK?lng=en.

Other stocks in the Pharmaceutical Retailers sector

• Fangzhou (6086.HK), score 9/10, P/FCF 14.5×
• JD Health International (JDHEAL19.BK), score 8/9, P/FCF 9.6×
• Healthlead Public (HL.BK), score 8/10, P/FCF 7.5×
• Clicks Group (CLS.JO), score 8/10, P/FCF 12.1×

Go further

👉 See the full interactive analysis of PEVE.JK

Other resources : All stocks in the Pharmaceutical Retailers sector.